NeurAxis, Inc. (NRXS)
NeurAxis, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
NeurAxis, Inc. (NRXS) is a Biotechnology company based in US with a market capitalization of $86.8M. Revenue grew 32.9% year-over-year and free cash flow was negative at -$6.5M. This page tracks NRXS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 21 employees · IPO Aug 9, 2023
Valuation
Valuation & price
$7.87as of May 17, 2026· -10.7% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
25.54
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$86.8M
Market cap
32.9%
Revenue growth (YoY)
84.2%
Gross margin
-$6.5M
Free cash flow (USD)
-$4.5M
Net debt
Net cash position
31.3%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2020 → 2025
Free cash flow by year
2020 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 12, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- FinancingJul 23, 2026Filing
Securities Registration
- 8-K eventJul 10, 2026Filing
Stock Dividend Declared
- 8-K eventJun 12, 2026Filing
Incentive Plan Amendment
- Quarterly reportMay 12, 2026Filing
10-Q Filed
- 8-K eventApr 22, 2026Filing
At The Market Offering Update
- 8-K eventApr 21, 2026Filing
Earnings Release
- Insider buyApr 3, 2026Filing
Insider Buy $16KCarrico Brian Allen · Director, Chief Executive Officer · $15.8K
- Insider buyApr 3, 2026Filing
Insider Buy $1KCarrico Thomas Joeseph · CRO, CCO, CPO · $1.3K
- Insider buyApr 3, 2026Filing
Insider Buy $15KHenrichs Timothy Robert · Chief Financial Officer · $14.9K
Questions
Frequently asked questions
What is NeurAxis, Inc.'s market cap?
NeurAxis, Inc. (NRXS) has a market capitalization of $86.8M.
What is NRXS's P/E ratio?
A meaningful P/E ratio is not available for NRXS — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is NRXS's price-to-book (P/B) ratio?
NRXS trades at 25.54 times book value per share.
Are insiders buying NRXS stock?
SEC Form 4 filings show no open-market insider buys at NeurAxis, Inc. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.